VIVAXIM

This brand name is authorized in Canada, Hong Kong, New Zealand, Singapore, South Africa

Active ingredients

The drug VIVAXIM contains a combination of these active pharmaceutical ingredients (APIs):

1 Hepatitis A, inactivated vaccine UNII G54MT8V18G - HEPATITIS A VIRUS

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. Read about Hepatitis A, inactivated vaccine

2 Typhoid purified polysaccharide antigen UNII 7194H8W3KT - SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN

Read about Typhoid purified polysaccharide antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07CA10	Typhoid-hepatitis A	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02248361
Country: HK	Department of Health Drug Office	Identifier(s): 55713
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10592
Country: SG	Health Sciences Authority	Identifier(s): 13670P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/30.1/0025